Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Research of Value of Free Methylated DNA Detect in Lung Cancer on the Diagnosis and Treatment of Paraneoplastic Syndrome of Nervous System

NCT04454853 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04454853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04454853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Research of Value of Free Methylated DNA Detect in Lung Cancer on the Diagnosis and Treatment of Paraneoplastic Syndrome of Nervous System
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
July 1, 2019
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paraneoplastic neurological syndrome